Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ASIC
ASIC logo

ASIC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ategrity Specialty Insurance Company Holdings (ASIC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
18.900
1 Day change
0.48%
52 Week Range
25.300
Analysis Updated At
2026/03/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ategrity Specialty Insurance Company Holdings (ASIC) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown strong financial growth in its latest quarter and has a differentiated business model, the recent downgrade by Citi and the lack of significant positive trading signals or catalysts suggest a balanced risk/reward profile. The technical indicators and price trend also do not indicate a compelling entry point currently.

Technical Analysis

The MACD is negative and expanding, suggesting bearish momentum. RSI is neutral at 33.665, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 19.602), but there is no strong technical signal for a reversal or breakout.

Positive Catalysts

  • The company's Q4 financials showed strong growth, with revenue up 30.82% YoY, net income up 76.20% YoY, and EPS up 25.00% YoY. Analysts from JPMorgan and Barclays have raised their price targets recently, citing strong premium growth and a technology-driven platform.

Neutral/Negative Catalysts

  • Citi downgraded the stock to Neutral from Buy, citing valuation concerns after a 36% increase in share price since the Q4 report. The MACD and RSI suggest bearish momentum, and there is no recent news or significant trading activity from hedge funds or insiders.

Financial Performance

In Q3 2025, the company reported strong financial growth with revenue increasing to $116.1 million (up 30.82% YoY), net income rising to $22.66 million (up 76.20% YoY), and EPS increasing to 0.45 (up 25.00% YoY). Gross margin remained unchanged.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. Citi downgraded the stock to Neutral from Buy with a $27 price target, citing valuation concerns. JPMorgan and Barclays maintain Overweight ratings with price targets of $27 and $26, respectively, highlighting strong growth and differentiation in the specialty insurance market.

Wall Street analysts forecast ASIC stock price to rise
4 Analyst Rating
Wall Street analysts forecast ASIC stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 18.810
sliders
Low
23
Averages
25
High
27
Current: 18.810
sliders
Low
23
Averages
25
High
27
Citi
Buy -> Neutral
downgrade
$27
AI Analysis
2026-02-26
Reason
Citi
Price Target
$27
AI Analysis
2026-02-26
downgrade
Buy -> Neutral
Reason
Citi downgraded Ategrity Specialty to Neutral from Buy with a $27 price target.
Citi
Matthew Heimermann
Buy -> Neutral
downgrade
$27
2026-02-26
Reason
Citi
Matthew Heimermann
Price Target
$27
2026-02-26
downgrade
Buy -> Neutral
Reason
Citi analyst Matthew Heimermann downgraded Ategrity Specialty to Neutral from Buy with an unchanged price target of $27. The firm cites valuation for the downgrade, seeing a balanced risk/reward with the shares up 36% since the Q4 report. Ategrity's valuation now looks "more reasonable" relative to the company's fundamentals, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ASIC
Unlock Now

People Also Watch